Lindsey Brown Fetzer
Lindsey Fetzer focuses her practice on white collar and corporate compliance matters, including healthcare fraud and abuse issues. Lindsey has represented clients in foreign and domestic matters involving the U.S. Department of Justice, the U.S. Securities and Exchange Commission, and other primary enforcement agencies.
Memberships
American Bar Association
American Health Law Association (AHLA)
Women’s White Collar Defense Association
Representative Experience
-
Read More
Obtained a jury trial victory on six of seven counts for the former vice president of Pilot Flying J who, along with three others, was accused of seeking to defraud customers
-
Read More
Represented a global healthcare company in relation to an investigation conducted by DOJ and HHS-OIG into alleged violations of the False Claims Act. The alleged false claims involved the manner in which certain negative pressure wound therapy devices were being marketed and distributed as durable medical equipment. Conducted an internal investigation and negotiated a favorable settlement with DOJ, HHS-OIG, and counsel for the relator. No post-settlement oversight was required.
-
Read More
Represented a publicly-traded oilfield services company in an investigation of alleged anti-corruption violations in Africa
-
Read More
Conducted a multi-country FCPA and local law investigation in Southeast Asia for a U.S. company
-
Read More
Advised a multinational company in review of potential anti-money laundering violations
-
Read More
Represented ArthroCare Corporation in a five-year U.S. Department of Justice investigation into allegations of healthcare and securities fraud resulting in a Deferred Prosecution Agreement and no post-settlement monitoring.
-
Read More
Represented a group of diagnostic imaging centers in a U.S. Department of Justice and HHS-OIG investigation alleging False Claims Act violations. Negotiated resolution with no post-investigation monitoring or corporate integrity agreement.
-
Read More
Represented a publicly-traded multinational company in conducting an internal investigation and making voluntary disclosure of FCPA violations to Securities and Exchange Commission (SEC); resulted in formal declination of prosecution by the SEC
-
Read More
Advised a publicly traded U.S. company on anti-corruption due diligence related to the potential acquisition of a U.S. company with an active unresolved DOJ and SEC FCPA investigation
-
Read More
Represented a Fortune 500 U.S. automotive company in an FCPA investigation by U.S. Justice Department (DOJ) and Securities and Exchange Commission (SEC)
Publications
Past Events
Media Mentions & Firm News
Accolades
Best Lawyers: Ones To Watch — Health Care Law (2021)
Washington, D.C. Super Lawyers “Rising Star” (2015-2020)
Washington and Lee Journal of Civil Rights and Social Justice — Lead Articles Editor
